期刊
MOLECULAR BIOTECHNOLOGY
卷 51, 期 3, 页码 212-220出版社
HUMANA PRESS INC
DOI: 10.1007/s12033-011-9458-7
关键词
Breast cancer; Cancer stem cell marker; Diagnostics probe; CD44-binding peptides; M13 phage display
资金
- Korea Science and Engineering Foundation
- Ministry of Education, Science and Technology [2009-0081812]
- National Research Foundation of Korea [2008-2003935] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
CD44, a cancer-associated membrane glycoprotein involved in cell adhesion and tumor progression, has been implicated as a cancer stem cell antigen in several cancers including breast cancer. If the detection sensitivity of CD44 as an early marker for cancer could be improved, this would have important clinical applications. As compared with early stage treatments of other kinds of cancer, treatment of breast cancer is more likely to results in positive outcomes, so this early detection is crucial. Therefore, CD44 is a potential diagnostic target for cancer detection. Herein, we have used a peptide library to screen novel diverse peptides that bind to CD44 with high affinity and characterized the specific binding of these peptides. Our work provides a basis to develop novel diagnostic peptides which may replace antibodies as CD44 detection probes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据